Clinical Trial Update: Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a combination chemotherapy regimen with infusion of leukocytes in patients with hematologic cancers, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED